CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

opt101

Peptideexperimental

Clinical trial activity

4 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Dec 20, 2020 (NCT04589403)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2025

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06964087Phase 2May 27, 2025Op-T LLC
NCT06669403Phase 1Feb 28, 2025Op-T LLC
NCT05428943Phase 1Sep 27, 2022Op-T LLC
NCT04589403Phase 1Dec 20, 2020IMMUNOe, Op-T LLC
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Op-T LLCFor profit4422020
IMMUNOeAcademic/Hospital1012020
2 organizations
Page 1 / 1